bit.bio's 2025 Sustainability Report: A Commitment to Ethics and Environment
bit.bio's 2025 Sustainability Report: A Commitment to Ethics and Environment
On December 2, 2025, bit.bio, a trailblazer in cell programming technology, released its 2025 Corporate Sustainability Report. This document reaffirms the company’s pledge to integrate ethical and sustainable practices throughout its operations. As a leading player in cellular technology, bit.bio aims to revolutionize research methodologies while adhering to transparent governance principles.
The report outlines a robust framework for measuring progress aligned with the United Nations Sustainable Development Goals (SDGs), demonstrating how bit.bio has made tangible year-over-year advancements. The company emphasizes a transparent approach, aiming to maintain accountability to customers, partners, investors, and its workforce.
Building on the Foundation of the 2024 Report
This 2025 report builds on the commitments established in bit.bio's inaugural 2024 Sustainability Report, which focused on three primary SDGs: Good Health and Well-Being (SDG 3), Industry, Innovation, and Infrastructure (SDG 9), and Life on Land (SDG 15). It also incorporated seven secondary SDGs guiding daily operations. Bit.bio’s latest publication showcases the implementation of these commitments, translating them into operational changes and measurable impacts over the past year.
Global Shift from Animal Testing
The report is particularly timely, aligning with ongoing efforts in the UK and US to reduce animal testing and adopt New Approach Methodologies (NAMs). These strategies aim to promote research models based on human cells rather than traditional animal models. bit.bio's ioCells portfolio of human iPSC-derived products stands at the forefront of this movement, offering viable alternatives that support the evolving regulatory frameworks.
Przemek Obloj, CEO of bit.bio, expressed excitement over the report's release, stating, "Sustainability and ethics are core to our operations and innovations. As regulations shift away from animal testing, we aim to make high-quality human cells accessible, making non-animal research options practical for scientists."
Key Insights from the 2025 Sustainability Report
- - Reducing Reliance on Animal Testing: Bit.bio's ioCells are designed to facilitate a transition away from animal testing in preclinical research. Although not a complete substitute for large-scale animal studies, these offerings present more human-relevant alternatives that can improve reproducibility and adapt to new regulatory standards.
- - Promoting Gender Equity in Science: Historically, biomedical research has predominantly relied on male-derived cell models. Bit.bio is addressing this gap by expanding its development of female donor-derived cell lines, thus enhancing the scientific relevance and reflecting the diversity of patients in research.
- - Recognized Sustainability Achievements: For the second consecutive year, bit.bio received Platinum status in the Green Impact Awards, an independent recognition of the company's commitment to improving sustainable lab practices and responsible consumption.
- - Innovative Laboratory Practices: The report outlines new, energy-efficient protocols in lab operations, including a trial of freezer temperature management that significantly reduces energy consumption while maintaining sample integrity.
- - Detailing Carbon Footprint: For the first time, the report presents comprehensive metrics on electricity, gas, travel, and waste, ensuring rigorous transparency while maintaining confidentiality of sensitive business data.
- - Employee-Driven Initiatives: Focused on sustainability, bit.bio has undertaken operational changes resulting from employee feedback, showcasing how workforce engagement can lead to improved practices.
- - Attracting Talent with Ethical Commitment: A strong dedication to ethics and sustainability plays a crucial role in attracting and retaining talent at bit.bio. New hires cite the company's leadership in these areas as motivators for joining the firm.
Conclusion
As echoed by Prof. Marie Claire Cordonier Segger, Chair of the Ethics and Sustainability Board at bit.bio, "This report reflects bit.bio's commitment to shaping a future where science, ethics, and sustainability advance together." By setting high standards for responsible human cell usage, bit.bio is paving the way for long-term impacts in the life sciences industry. The integration of innovative technology and ethical practices places bit.bio at the forefront of sustainable advancements in research, ensuring a better future for both science and society.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.